<\/p>\n
NEW FILINGS<\/p>\n
Company: Fangdd Network Group Ltd.
\nSymbol: DUO
\nDescription: They have fundamentally revolutionized the way real estate agents conduct business through their SaaS-based solutions that help to connect them with essential business resources, including customers, property listings, capital and transaction data.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, Citigroup, UBS, CICC, AMTD
\nFiled: 10-8-19
\nListed Cash Raise: $150m<\/p>\n
Company: Oyster Point Pharma, Inc
\nSymbol: OYST
\nDescription: They are a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): JP Morgan, Cowen, Piper Jaffray
\nFiled: 10-4-19
\nListed Cash Raise: $85m<\/p>\n
Company: Q&K International Group Limited
\nSymbol: QK
\nDescription: They are a leading technology-driven long-term apartment rental platform in China, offering young, emerging urban residents conveniently-located, ready-to-move-in, and affordable branded apartments as well as facilitating a variety of value-added services.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, CICC
\nFiled: 10-7-19
\nListed Cash Raise: $100m<\/p>\n
TERMS ADDED<\/p>\n
Company: BRP Group, Inc.
\nSymbol: BRP
\nDescription: They are a rapidly growing independent insurance distribution firm delivering solutions that give our clients the peace of mind to pursue their purpose, passion and dreams.
\nShares: 16.4 million
\nPrice Range: $14.00-$16.00
\nTrade Date: Thursday, 10\/24
\nUnderwriter(s): J.P. Morgan, BofA Merrill Lynch, Jefferies, Wells Fargo Securities
\nCo-Manager: Raymond James, Keefe Bruyette & Woods
\nTerms Added: 10-11-19<\/p>\n
Company: BellRing Brands, Inc.
\nSymbol: BRBR
\nDescription: They are a rapidly growing leader in the global convenient nutrition category, aiming to enhance the lives of our consumers by providing them with highly nutritious, great-tasting products they can enjoy throughout the day.
\nShares: 30 million
\nPrice Range: $16.00-$19.00
\nMarket Cap: $2.05b-$2.45b
\nTrade Date: Thursday, 10\/17
\nUnderwriter(s): Morgan Stanley, Citigroup, J.P. Morgan, Goldman Sachs
\nCo-Manager: BofA Merrill Lynch, Barclays, BMO Capital Markets, Credit Suisse, Evercore ISI, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities, HSBC, Nomura, PNC Capital Markets, Rabo Securities, UBS Investment Bank
\nTerms Added: 10-7-19<\/p>\n
Company: innate Pharma S.A.
\nSymbol: IPHA
\nDescription: They are a biotechnology company focused on discovering, developing and commercializing first-in-class therapeutic antibodies designed to harness the immune system for the treatment of oncology indications with significant unmet medical need. Their ordinary shares are listed on Euronext Paris under the symbol “IPH.”
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: Thursday, 10\/17
\nUnderwriter(s): Citigroup, SVB Leerink, Evercore ISI
\nTerms Added: 10-4-19<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,1536],"tags":[],"class_list":["post-10320","post","type-post","status-publish","format-standard","hentry","category-ipo","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/10320","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=10320"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/10320\/revisions"}],"predecessor-version":[{"id":10321,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/10320\/revisions\/10321"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=10320"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=10320"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=10320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}